Human testing of the first anti-nicotine vaccine has begun, according to
British drugs company Xenova. Medical director John Roberts says the drug could
help people quit because it prevents nicotine acting on the brain and so stops
addiction. Nicotine patches or gum simply substitute inhaled nicotine with a
more benign form. The vaccine will work best for smokers who risk relapsing
after quitting. The vaccine will stop a lapse of will power “sending you back to
the beginning of the craving cycle”, says Roberts.
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
Popular articles
Trending New Scientist articles
1
Where, when and how to watch the 2026 solar eclipse
2
Remote-controlled cockroach swarm can now breathe underwater
3
If you aren't terrified by this heatwave, you should be
4
Our verdict on The Selfish Gene: An unpopular piece of popular science
5
We鈥檝e uncovered a master gene that switches on human development
6
Ancient human DNA found on cave art for the first time
7
You should turn off fans when it's too hot 鈥 but how hot is too hot?
8
Neuroscience can't tell us the way to govern people's brains
9
Screwworm could be the first species targeted by an 'extinction drive'
10
Fully autonomous drones have killed human soldiers for the first time
